immatics biotechnologies GmbH (4A3) — Cash Flow Quality Index
immatics biotechnologies GmbH (4A3) has a Cash Flow Quality Index of -1.21x as of December 2024. Operating cash flow of €-58.48 Million is below net income of €48.39 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 4A3 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
immatics biotechnologies GmbH Cash Flow Quality Index (2022–2024)
Historical Cash Flow Quality Index for immatics biotechnologies GmbH across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see immatics biotechnologies GmbH operating cash flow efficiency.
Annual Cash Flow Quality Index for immatics biotechnologies GmbH (2022–2024)
Year-by-year earnings quality comparison for immatics biotechnologies GmbH.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -9.63x | €-158.03 Million | €16.41 Million | ▼ -488.3% |
| 2022 | 2.48x | €100.13 Million | €40.38 Million | — |